Stephanie Goletz
8PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 28, 2026
Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo.Gefei Du, Shirin Emtenani, Dennis Niese
|Feb 27, 2026
Comparative performance of four immunoassays for antilaminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded study.Stephanie Goletz, Norito Ishii, Charlotte Kiehne
|Aug 06, 2025
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series.Kaan Yilmaz, Stephanie Goletz, Christoph M Hammers
|Jul 01, 2024
Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson disease.Jonathan Tegtmeyer, Maurizio Romagnuolo, Christoph M Hammers
|Mar 28, 2024
Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit.Stephanie Goletz, Christian Probst, Lars Komorowski
|Nov 06, 2023
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm
Pageof 2
Frequent Collaborators
4 joint publications
Enno Schmidt
2 joint publications
Maike M Holtsche
2 joint publications
Takashi Hashimoto
2 joint publications
Manuela Pigors
2 joint publications
Sabrina Patzelt
2 joint publications
Shirin Emtenani
2 joint publications
Katja Bieber
2 joint publications
Nina van Beek
2 joint publications
Christian Probst
2 joint publications
Lars Komorowski
